(Q46898268)

26 December 2017

title

COX-2 inhibitors modulate IL-12 signaling through JAK-STAT pathway leading to Th1 response in experimental allergic encephalomyelitis (English)

1 reference

26 December 2017

author name string

Gladson Muthian

1

1 reference

26 December 2017

Himanshu P Raikwar

2

1 reference

26 December 2017

Caroline Johnson

3

1 reference

26 December 2017

Johnson Rajasingh

4

1 reference

26 December 2017

Amit Kalgutkar

5

1 reference

26 December 2017

Lawrence J Marnett

6

1 reference

26 December 2017

John J Bright

7

1 reference

26 December 2017

publication date

1 January 2006

1 reference

26 December 2017

Journal of Clinical Immunology

published in

1 reference

26 December 2017

volume

26

1 reference

26 December 2017

issue

1

1 reference

26 December 2017

page(s)

73-85

1 reference

26 December 2017

https://scigraph.springernature.com/pub.10.1007/s10875-006-8787-y

exact match

0 references

cites work

Curcumin inhibits experimental allergic encephalomyelitis by blocking IL-12 signaling through Janus kinase-STAT pathway in T lymphocytes

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10875-006-8787-Y

Regulation of interleukin 12 p40 expression through an NF-kappa B half-site

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10875-006-8787-Y

How many people in the world have multiple sclerosis?

21 January 2018

1 reference

12 December 2020

Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand

1 reference

12 December 2020

Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor)

1 reference

12 December 2020

Elevated serum levels of interleukin-12 in chronic progressive multiple sclerosis

1 reference

12 December 2020

Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity

1 reference

12 December 2020

Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins

1 reference

12 December 2020

Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases.

1 reference

12 December 2020

Mediation of inflammation by cyclooxygenase-2.

1 reference

12 December 2020

Cyclooxygenases 1 and 2

1 reference

12 December 2020

Second signal activity of IL-12 on the proliferation and IL-2R expression of T helper cell-1 clone

1 reference

12 December 2020

Cyclooxygenase in biology and disease

1 reference

12 December 2020

Prevention of experimental allergic encephalomyelitis via inhibition of IL-12 signaling and IL-12-mediated Th1 differentiation: an effect of the novel anti-inflammatory drug lisofylline

1 reference

12 December 2020

Theories of the etiology of multiple sclerosis: a critical review

1 reference

12 December 2020

Novel genetic regulation of T helper 1 (Th1)/Th2 cytokine production and encephalitogenicity in inbred mouse strains

1 reference

12 December 2020

TGF-beta inhibits IL-12-induced activation of Jak-STAT pathway in T lymphocytes

1 reference

12 December 2020

Animal models of demyelination.

1 reference

12 December 2020

Mediation of inflammation by encephalitogenic cells: interferon gamma induction of nitric oxide synthase and cyclooxygenase 2

1 reference

12 December 2020

Tyrphostin B42 inhibits IL-12-induced tyrosine phosphorylation and activation of Janus kinase-2 and prevents experimental allergic encephalomyelitis

1 reference

12 December 2020

Animal models for autoimmune demyelinating disorders of the nervous system

1 reference

12 December 2020

Multiple sclerosis: deeper understanding of its pathogenesis reveals new targets for therapy.

1 reference

12 December 2020

Drugs in development for the treatment of multiple sclerosis: antigen non-specific therapies--an update

1 reference

12 December 2020

Immunological aspects of demyelinating diseases

1 reference

12 December 2020

An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease.

1 reference

12 December 2020

The role of IL-12 in the induction of organ-specific autoimmune diseases

1 reference

12 December 2020

Immunomodulatory drugs for multiple sclerosis: a systematic review of clinical and cost effectiveness

1 reference

12 December 2020

Design of selective inhibitors of cyclooxygenase-2 as nonulcerogenic anti-inflammatory agents.

1 reference

12 December 2020

Arachidonic acid oxygenation by COX-1 and COX-2. Mechanisms of catalysis and inhibition

1 reference

12 December 2020

Ester and amide derivatives of the nonsteroidal antiinflammatory drug, indomethacin, as selective cyclooxygenase-2 inhibitors

1 reference

12 December 2020

Mechanisms of immune injury in multiple sclerosis

1 reference

12 December 2020

Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12.

1 reference

12 December 2020

Outcome of specific COX-2 inhibition in rheumatoid arthritis.

1 reference

12 December 2020

Potential role of prostaglandins and leukotrienes in multiple sclerosis and experimental allergic encephalomyelitis

1 reference

12 December 2020

Contingent genetic regulatory events in T lymphocyte activation

1 reference

12 December 2020

Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4

1 reference

12 December 2020

Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes

1 reference

12 December 2020

Cyclooxygenase regulates angiogenesis induced by colon cancer cells

1 reference

12 December 2020

Expression of IL-12 in CNS and lymphoid organs of mice with experimental allergic encephalitis

1 reference

12 December 2020

Differential influence of interleukin-12 in the pathogenesis of autoimmune and virus-induced central nervous system demyelination.

1 reference

12 December 2020

Astrocyte-targeted expression of IL-12 induces active cellular immune responses in the central nervous system and modulates experimental allergic encephalomyelitis.

1 reference

12 December 2020

The effect of cyclooxygenase-2 inhibitor on experimental allergic neuritis

1 reference

12 December 2020

Cyclooxygenase 2 inhibitors: discovery, selectivity and the future

1 reference

12 December 2020

Forum: reactive species of peroxynitrite

1 reference

12 December 2020

Interleukin-12 regulates the proliferation of Th1, but not Th2 or Th0, clones.

1 reference

12 December 2020

Biochemically based design of cyclooxygenase-2 (COX-2) inhibitors: facile conversion of nonsteroidal antiinflammatory drugs to potent and highly selective COX-2 inhibitors

1 reference

12 December 2020

Peroxisome proliferator-activated receptor-gamma agonists inhibit experimental allergic encephalomyelitis by blocking IL-12 production, IL-12 signaling and Th1 differentiation

1 reference

12 December 2020

Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells

1 reference

12 December 2020

Quercetin, a flavonoid phytoestrogen, ameliorates experimental allergic encephalomyelitis by blocking IL-12 signaling through JAK-STAT pathway in T lymphocyte

1 reference

12 December 2020

IL-12 augments antigen-dependent proliferation of activated T lymphocytes

1 reference

12 December 2020

Sodium salicylate-induced amelioration of experimental autoimmune encephalomyelitis in Lewis rats is associated with the suppression of inducible nitric oxide synthase and cyclooxygenases

1 reference

12 December 2020

TGF-beta inhibits IL-2-induced tyrosine phosphorylation and activation of Jak-1 and Stat 5 in T lymphocytes.

1 reference

12 December 2020

10.1007/S10875-006-8787-Y

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017